Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has provided an announcement.
Charmacy Pharmaceutical Co., Ltd. has announced an updated final dividend for the financial year ended 31 December 2025, declaring a payout of RMB 0.3 per share, with the exact Hong Kong dollar amount and exchange rate to be confirmed. The dividend is subject to shareholder approval on 22 May 2026, with an ex-dividend date of 27 May, a record date of 5 June, and payment scheduled for 25 June 2026.
The company has detailed the withholding tax arrangements for different categories of shareholders, setting a 10% tax rate for non-resident enterprise and individual shareholders and a 20% rate for PRC-resident individual shareholders. These tax rules, aligned with PRC laws and relevant tax treaties, clarify net dividend entitlements and may influence the after-tax returns and planning considerations of both domestic and overseas investors in the company’s H shares.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a Hong Kong-listed pharmaceutical company operating in the healthcare sector. It is engaged in the distribution and sale of pharmaceutical products, serving both institutional and individual customers, with its H shares traded on the Stock Exchange of Hong Kong under stock code 02289.
Average Trading Volume: 2,750
Technical Sentiment Signal: Sell
Current Market Cap: HK$628.6M
Find detailed analytics on 2289 stock on TipRanks’ Stock Analysis page.